Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LODESTAR: Statin Strategies in CAD
NCT02579499Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Sep 2016
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, rosuvastatin in coronary artery disease (CAD), sponsored by Yonsei University. Status: unknown.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02579499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579499.